Top 50 Ai For Computational Biology in Latin America

The startup specializes in identifying bioactive ribonucleic acid (RNA) from natural sources using machine learning and bioinformatics techniques. This enables researchers to enhance human health and resilience in response to environmental stressors through the application of RNA technologies.

Nintx Next Innovative Therapeutics utilizes proprietary technologies such as xGIbiomics, which simulates the human gastrointestinal system, and GAIApath, an AI-driven analytics platform, to identify and develop plant-based therapies targeting multifactorial diseases. By leveraging Brazil's rich biodiversity, Nintx aims to create multi-target therapies that modulate human biological systems and the microbiome, addressing the limitations of traditional single-target drug approaches.

Embryoxite develops an AI-powered platform that analyzes embryo metabolomic data, genetic profiles, and morphokinetic imaging to assess implantation potential in pre-implantation embryos. This technology addresses the high failure rate of embryo implantation in IVF procedures by providing objective, data-driven insights that enhance selection accuracy and improve pregnancy outcomes.

Cromai utilizes artificial intelligence to analyze agricultural images for precise identification and quantification of invasive plant species, enabling targeted herbicide application. This technology reduces herbicide usage by up to 65%, enhancing operational efficiency and sustainability in crop management.

metaBIX Biotech has developed a platform that utilizes hardware, biotechnology, and artificial intelligence to monitor airborne pathogens, providing early warnings of potential disease outbreaks in plants, animals, and humans. This technology enables clients to implement preventive measures at least two weeks before an outbreak occurs, enhancing safety and public health.

Onward Assist is a predictive analytics platform that utilizes AI-driven image analysis to enhance cancer diagnosis by identifying biomarkers and reducing reporting time by 30-40%. The platform addresses the lack of effective cancer scoring tools tailored for diverse populations, enabling pathologists to make more accurate treatment decisions efficiently.

DeepAgro utilizes generative AI for real-time weed detection and selective spraying, significantly reducing agrochemical usage by up to 90% based on weed density in soybean crops. Their platform also integrates agricultural data, enabling farmers to monitor crop health and optimize resource allocation efficiently.

Onc.AI develops an AI-powered clinical management platform that utilizes a comprehensive oncology real-world dataset, including diagnostic imaging and genomics, to enhance treatment decision-making for metastatic lung cancer patients undergoing PD-1 immunotherapy. The platform provides actionable insights that enable oncologists to improve patient outcomes by optimizing treatment strategies based on real-world evidence.

The startup develops an artificial intelligence-based respiratory health monitoring system that analyzes individual and population-level respiratory data to track disease progression and treatment outcomes. This technology enables healthcare providers to implement timely interventions for patients with respiratory illnesses, improving overall care quality.

PROSPERiA utilizes artificial intelligence to automatically analyze retinal images, providing personalized recommendations to prevent blindness caused by chronic diseases. The platform enhances early detection and treatment accessibility, addressing the critical issue of late diagnosis in diabetic patients.

MEDiC utilizes a proprietary CRISPR functional genomics platform combined with 3D tumor models to identify cancer biomarkers and novel drug targets with high precision. This approach addresses the challenge of missed potential biomarkers in current drug development, enhancing the accuracy of patient stratification for oncology treatments.

D-Matrix has developed Corsair, an AI inference platform that achieves 60,000 tokens per second with 1 ms latency for Llama3 8B models, significantly enhancing throughput and energy efficiency in datacenters. This technology addresses the high computational costs and energy consumption associated with large-scale AI inference, enabling organizations to scale their AI capabilities sustainably.

Ambient Scientific develops the GPX10, an ultra-low power AI microprocessor designed for on-device applications, enabling years of operation on a single coin cell battery. This technology addresses the limitations of cloud dependency by providing efficient, always-on AI capabilities for battery-powered edge devices, enhancing data privacy and reducing operational costs.

Precision Data provides a business intelligence platform that utilizes generative artificial intelligence to optimize access to over 8 billion lines of structured clinical data, enhancing real-world evidence studies in healthcare. The company addresses the challenge of data quality and accessibility, enabling healthcare organizations to make informed decisions based on accurate and comprehensive information.

Provides data science, machine learning, and artificial intelligence consulting to help organizations in Colombia and LATAM leverage data for improved decision-making, operational efficiency, and cost reduction. Specializes in developing predictive models, optimizing processes, and implementing AI strategies tailored to industries such as healthcare, finance, agriculture, and retail.

The startup has developed a proprietary platform for engineering proteins that enables the self-assembly of viral proteins and the creation of nanobiodevices and nanobiomaterials. This technology facilitates advancements in immunotherapy, vaccine development, and personalized medicine, providing clients with effective solutions for diagnostics and therapeutics.

EnCharge AI develops a scalable analog in-memory computing platform that enhances AI performance by achieving 20 times higher efficiency and 10 times lower total cost of ownership compared to traditional GPU solutions. This technology enables on-device processing, significantly reducing CO2 emissions and ensuring data privacy while making advanced AI accessible beyond cloud infrastructure.

Qdrant provides an open-source vector search database that enables high-performance similarity searches for high-dimensional data, facilitating the development of applications for matching, searching, and recommending. By efficiently processing embeddings from neural networks, Qdrant allows businesses to leverage unstructured data for enhanced data analysis and personalized user experiences.

This food technology company utilizes AI algorithms to create plant-based meat and dairy alternatives from ingredients like pineapple, coconut, and chickpeas, replicating the taste and texture of animal products. Their offerings provide a sustainable source of fiber, calcium, and protein, addressing the demand for healthier and environmentally friendly food options.

Munai develops AI algorithms for hospitals and insurance providers to enhance patient management and reduce healthcare costs. Their platform enables efficient patient monitoring and data analysis, leading to improved clinical decision-making and significant cost savings.

Clear Labs is a biotechnology firm that utilizes a genomics system to enhance diagnostic accuracy in clinical and application sectors. The company addresses the complexity of traditional diagnostic processes by providing streamlined genomic analysis, enabling faster and more reliable results.

Beeing Company utilizes artificial intelligence and neural networks to perform genetic analysis of honey bee queens, ensuring the preservation of bee species and promoting biodiversity. Their certification process guarantees that beekeepers can verify the quality and health of their bees, facilitating access to international markets.

Koniku develops an organic neurocomputation platform that integrates biological neurons with silicon chips to create highly sensitive odor detection systems. This "brain-on-chip" technology offers preclinical testing services for mapping volatile organic compounds, enabling advanced applications in odor positioning and surveillance.

TAXON utilizes artificial intelligence and genomic analysis to enhance soil microbiome understanding, enabling farmers and biotech companies to optimize crop yields and reduce reliance on agrochemicals. By providing detailed insights into microbial diversity and functionality, TAXON helps clients make informed decisions that lead to sustainable agricultural practices and improved productivity.

Huna develops an AI engine that analyzes routine blood test data to identify risk patterns for early cancer detection and other chronic diseases. This technology enables healthcare providers to classify patients by risk level, improving clinical decision-making and increasing the chances of successful treatment while reducing overall healthcare costs.

This biotechnology platform decodes microbiomes to identify and manage their potential in productive environments. By providing insights from microbiome data, the platform helps researchers make informed decisions to minimize environmental impact and enhance performance.

Arkangel AI is a no-code platform that transforms medical data into AI algorithms for early disease detection, enabling healthcare organizations to build and deploy tailored solutions efficiently. By streamlining processes such as patient triage and drug adverse effect prediction, Arkangel AI enhances healthcare outcomes while significantly reducing operational costs.

The startup develops a geospatial data intelligence platform that integrates multispectral and hyperspectral satellite and drone imagery with machine learning algorithms for environmental and water body monitoring. This technology enables clients to efficiently track changes in ecosystems and agribusiness, providing actionable insights for sustainable management.

BioHeuris combines synthetic biology and gene editing to create herbicide-resistant crops that enable sustainable weed management. This approach reduces the reliance on toxic herbicides and mitigates the evolution of herbicide-resistant weeds, promoting environmental sustainability in agriculture.

Aperture Therapeutics develops a drug discovery engine that utilizes extensive cell libraries representing genetic diversity to identify gene variants that confer protection against neurodegenerative diseases. By targeting specific RNA transcripts, the company aims to create therapies that can delay brain aging and improve outcomes for affected populations.

Kinzbio develops precision antimicrobial therapies using bacteriophages to target and eliminate specific bacterial pathogens. Their AI-driven platform rapidly identifies and optimizes phages for personalized treatments, offering a highly specific alternative to traditional antibiotics.

Comsentimento develops an AI-driven platform for clinical data transformation and research, focusing on enhancing cancer treatment and facilitating access to clinical trials. The platform provides healthcare professionals with actionable insights and support for chronic disease management, improving patient care and treatment adherence.

Yeda Health utilizes artificial intelligence to provide personalized dietary and lifestyle recommendations based on individual responses to food and continuous glucose monitoring data. This approach addresses the challenge of managing blood glucose levels by recognizing that each person's metabolic response is unique, enabling tailored strategies for metabolic stability.

The startup has developed a clinical research platform that utilizes machine learning to target the biological processes of aging, facilitating the discovery of therapies for age-related diseases such as cardiovascular and neurodegenerative conditions. By enabling pharmaceutical companies to enhance medical treatments, the platform addresses the need for more effective interventions in aging-related health issues.

Mundos provides a collaborative research platform that utilizes AI to analyze input topics and generate actionable insights, enabling professionals to capture and share tacit knowledge effectively. By transforming complex data into clear visualizations, Mundos enhances real-time teamwork and customizes outputs for tailored reporting.

The startup offers a healthcare platform that utilizes artificial intelligence and data mining to enhance treatment management for patients and medical providers. By enabling patients to identify specialists and appropriate treatments, the platform improves diagnostic analysis and user experience, ultimately reducing the time and resources required for patient care.

CytoEM Innovations decodes the electromagnetic identity of various cell types to precisely control their growth and behavior through interferometry. This technology addresses the challenges of low cell yield and high production costs in bioprocesses, enhancing efficiency in pharmaceutical and agricultural applications.

Begen is a platform that connects businesses with specialized AI developers, enabling efficient access to AI solutions while reducing development costs. It addresses the challenge of AI adoption by providing a controlled environment for companies to implement AI-driven innovations and streamline their operations.

This healthcare platform uses AI to analyze a patient's complete medical history, including medications and exam results, to generate intelligent diagnostic hypotheses. It helps medical professionals formulate accurate diagnoses by feeding patient characteristics into an algorithm, streamlining the diagnostic process.

AIMedic utilizes artificial intelligence to integrate diverse medical data sources, enhancing diagnostic accuracy and treatment selection for healthcare professionals. The platform supports patient monitoring through an intelligent assistant, providing validated educational resources and vital health updates to improve patient outcomes.

Base Cientifica offers comprehensive molecular and cellular research services to accelerate preclinical development and personalized medicine. They specialize in biological assay validation, biobanking, and molecular diagnostic assay development using PCR and NGS. Their services also include preclinical efficacy and safety studies, 3D organoid cultivation, and AI-driven R&D optimization.

The startup offers an ecosystem of AI agent-based tools that enhance human capabilities by facilitating the design, execution, and monitoring of collaborative processes between humans and AI. This approach addresses the challenges of inefficient workflows and communication, enabling users to improve productivity and decision-making through increased cognitive support and skill development.

SIENTIA™ is an AIOps platform that enables the seamless deployment of AI models in Operational Technology environments, transforming Proofs of Concept into production-ready solutions. By integrating industry data, SIENTIA™ accelerates AI scalability and operational efficiency for heavy-asset industries, delivering measurable results in under one second of inference time.

The startup operates a genomics platform that centralizes and integrates DNA data to provide precise diagnoses and personalized treatment plans through advanced data analysis and interpretation. By leveraging genomic information, the platform enables researchers to enhance health outcomes and preventive care strategies for individuals.

The startup has developed a molecular diagnostic platform that integrates advanced fluidics, engineering, and bioinformatics to create a user-friendly in vitro diagnostic system. This technology enables healthcare providers to deliver precise clinical genomic information to patients, enhancing accessibility to essential diagnostics for improved treatment outcomes.

The startup develops AI-powered applications that enhance decision-making by analyzing large datasets and providing actionable insights. This technology enables organizations to make data-driven choices more efficiently, reducing uncertainty and improving operational outcomes.

The startup utilizes a proprietary Generative Biology Platform and a Discovery Platform that integrate machine learning and multi-modal single-cell analysis to identify gene regulatory networks and develop targeted cell therapies for cancer. By precisely modulating gene expression in specific cell types, the company aims to enhance the efficacy of cell-based treatments, addressing the limitations of traditional cancer therapies.

Naturannova utilizes a computational platform that combines AI and bioinformatics to identify and analyze plant-based proteins, creating sustainable and clean label ingredients. The startup addresses the need for healthier food options by developing novel protein sources, such as their all-natural protein-based sweetener, through precision fermentation and laboratory testing.

MYNU is a biotechnology startup that utilizes genetic testing to analyze over 130 genes, creating personalized nutrition plans tailored to individual genetic profiles. By combining biotechnological research and artificial intelligence, MYNU addresses the need for customized dietary solutions that enhance personal well-being and support specific health goals.

This startup has developed a biotech platform that enhances the drug discovery process through predictive toxicology and drug quality assurance, specifically tailored for the Latin American market. By optimizing research and development workflows, the platform reduces time and costs while minimizing the reliance on animal testing.